Limits...
The emerging face of the HIV epidemic in the Middle East and North Africa.

Mumtaz GR, Riedner G, Abu-Raddad LJ - Curr Opin HIV AIDS (2014)

Bottom Line: A few studies found alarming prevalence of as much as 87.2% HIV prevalence among people who inject drugs in Tripoli, Libya.The new data from MENA indicate growing HIV epidemics among key populations across the region.There is heterogeneity, however, as to which key populations are affected and in what proportions in different countries.

View Article: PubMed Central - PubMed

Affiliation: aInfectious Disease Epidemiology Group, Weill Cornell Medical College - Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar bRegional Office of the Eastern Mediterranean, World Health Organization, Cairo, Egypt cDepartment of Public Health, Weill Cornell Medical College, Cornell University, New York, New York, USA dVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

ABSTRACT

Purpose of review: A volume of quality HIV data has materialized recently in the Middle East and North Africa (MENA). This review provides a thematic narrative of the patterns of HIV infection transmission in this region in light of these data.

Recent findings: Tens of integrated bio-behavioral surveillance surveys among hard-to-reach key populations at higher risk have been conducted in MENA in the recent years. Many of the studies reported appreciable and growing HIV prevalence. A few studies found alarming prevalence of as much as 87.2% HIV prevalence among people who inject drugs in Tripoli, Libya. The discovery of these hitherto hidden epidemics was unsettling to some authorities after years in which the importance of a focus on HIV prevention among key populations was not recognized.

Summary: The new data from MENA indicate growing HIV epidemics among key populations across the region. There is heterogeneity, however, as to which key populations are affected and in what proportions in different countries. In a few countries, HIV appears to affect only one key population and often there is substantial geographical heterogeneity in HIV transmission. Data are indicative of a growing HIV disease burden in this part of the globe, in contrast with the declining epidemics in most other regions.

Show MeSH

Related in: MedlinePlus

Map of the MENA region including the countries that are covered in this review. MENA, Middle East and North Africa. Reproduced with permission from [2].
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC3921267&req=5

Figure 1: Map of the MENA region including the countries that are covered in this review. MENA, Middle East and North Africa. Reproduced with permission from [2].

Mentions: This review covers the 23 countries that are part of the MENA definitions of the three United Nations organizations leading most HIV/AIDS efforts in the region: the Joint United Nations Programme on HIV/AIDS (UNAIDS), the Eastern Mediterranean Regional Office of the World Health Organization (WHO/EMRO), and the World Bank. These countries share historical, sociocultural, linguistic, and religious characteristics; and are usually included together as part of HIV/AIDS programming for the region (Fig. 1).


The emerging face of the HIV epidemic in the Middle East and North Africa.

Mumtaz GR, Riedner G, Abu-Raddad LJ - Curr Opin HIV AIDS (2014)

Map of the MENA region including the countries that are covered in this review. MENA, Middle East and North Africa. Reproduced with permission from [2].
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC3921267&req=5

Figure 1: Map of the MENA region including the countries that are covered in this review. MENA, Middle East and North Africa. Reproduced with permission from [2].
Mentions: This review covers the 23 countries that are part of the MENA definitions of the three United Nations organizations leading most HIV/AIDS efforts in the region: the Joint United Nations Programme on HIV/AIDS (UNAIDS), the Eastern Mediterranean Regional Office of the World Health Organization (WHO/EMRO), and the World Bank. These countries share historical, sociocultural, linguistic, and religious characteristics; and are usually included together as part of HIV/AIDS programming for the region (Fig. 1).

Bottom Line: A few studies found alarming prevalence of as much as 87.2% HIV prevalence among people who inject drugs in Tripoli, Libya.The new data from MENA indicate growing HIV epidemics among key populations across the region.There is heterogeneity, however, as to which key populations are affected and in what proportions in different countries.

View Article: PubMed Central - PubMed

Affiliation: aInfectious Disease Epidemiology Group, Weill Cornell Medical College - Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar bRegional Office of the Eastern Mediterranean, World Health Organization, Cairo, Egypt cDepartment of Public Health, Weill Cornell Medical College, Cornell University, New York, New York, USA dVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

ABSTRACT

Purpose of review: A volume of quality HIV data has materialized recently in the Middle East and North Africa (MENA). This review provides a thematic narrative of the patterns of HIV infection transmission in this region in light of these data.

Recent findings: Tens of integrated bio-behavioral surveillance surveys among hard-to-reach key populations at higher risk have been conducted in MENA in the recent years. Many of the studies reported appreciable and growing HIV prevalence. A few studies found alarming prevalence of as much as 87.2% HIV prevalence among people who inject drugs in Tripoli, Libya. The discovery of these hitherto hidden epidemics was unsettling to some authorities after years in which the importance of a focus on HIV prevention among key populations was not recognized.

Summary: The new data from MENA indicate growing HIV epidemics among key populations across the region. There is heterogeneity, however, as to which key populations are affected and in what proportions in different countries. In a few countries, HIV appears to affect only one key population and often there is substantial geographical heterogeneity in HIV transmission. Data are indicative of a growing HIV disease burden in this part of the globe, in contrast with the declining epidemics in most other regions.

Show MeSH
Related in: MedlinePlus